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Using confocal microscopy, MEST-1-positive immunofluorescence was observed within various Trypanosoma
cruzi forms, except in cell-derived trypomastigotes. Glycosylinositol phosphorylceramides were identified by
thin-layer chromatography immunostaining as the antigens recognized by MEST-1 in these parasites. In
epimastigotes, labeling of MEST-1 coincided with acidic vesicles, indicating an internal localization of these
glycoconjugates.
Glycoconjugates containing galactofuranose (Gal-furanose)
residues have been described in fungi, bacteria, and trypano-
somatides such as Trypanosoma cruzi and Leishmania (4, 15–
17). Although the biological role of Gal-furanose residues is
still unclear, the postulated absence of Gal-furanose and ga-
lactofuranosidases in mammalian species suggests the intrigu-
ing hypothesis that terminal Gal-furanose residues play a cen-
tral role in survival of fungi and parasites by preventing the
action of the host’s glycosidases on their glycoconjugates. If
this hypothesis is correct, Gal-furanose residues are potentially
useful as specific target molecules for therapy of parasitic and
fungal diseases.
We recently characterized the mouse monoclonal antibody
(MAb) MEST-1 (immunoglobulin G3 [IgG3]) (16), which rec-
ognizes glycosylinositol phosphorylceramides (GIPCs) con-
taining terminal residues of -D-Gal-furanose, in either the
linkage 1-6, present in the Pb-1 antigen of Paracoccidioides
brasiliensis (6), or the linkage 1–3, present in GIPL-1 of Leish-
mania major (8).
In the present study, we analyzed the reactivity of MEST-1
with different forms of T. cruzi. In the infected host, the intra-
cellular dividing amastigotes give rise to trypomastigotes that
lyse the cell and spread the infection. Trypomastigotes may be
ingested by the triatomine vector and differentiate into divid-
ing epimastigotes and then metacyclic trypomastigotes, the
forms that are infectious to mammals. A lipopeptidophospho-
glycan currently termed GIPC has been described as the major
glycoconjugate of the T. cruzi epimastigote surface (3). It is a
GIPC with a well-known carbohydrate structure containing
one or two terminal Gal-furanose residues (5, 10). We ana-
lyzed the reactivity of MEST-1 with different forms of T. cruzi,
and with GIPCs purified from the parasites, by indirect immu-
nofluorescence (IFI), solid-phase radioimmunoassay (RIA),
and high-performance thin-layer chromatography (HPTLC)
immunostaining.
Epimastigotes were grown in liver infusion tryptose medium
with 10% fetal calf serum at 27°C (2). Trypomastigotes and
extracellular amastigotes were isolated from culture superna-
tants after 4 to 5 days infection of Vero cells with metacyclic
trypomastigotes (1). Amastigote preparation contained less
than 10% trypomastigotes, and trypomastigote preparation
contained less than 5% amastigotes. For IFI, formaldehyde-
fixed parasites were incubated on coverslips treated with 0.1%
polylysine (19). The adsorbed parasites were blocked with 5%
bovine serum albumin (BSA) in phosphate-buffered saline
(PBS) and incubated with MAb culture supernatant and 1%
BSA containing 0.01 mM 4,6-diamidino-2-phenylindole
(DAPI) and anti-mouse IgG conjugated to fluorescein isothio-
cyanate. The coverslips were examined on a Bio-Rad 1024-UV
confocal microscope (1). Controls performed using an irrele-
vant MAb (IgG3) showed no fluorescence. Strong fluorescence
was observed in epimastigotes (Fig. 1B) and extracellular
amastigotes (Fig. 1F), and to a lesser extent in metacyclic
trypomastigotes (Fig. 1D) and intracellular amastigotes (Fig.
1J). Epimastigotes showed strong labeling of vesicle-like com-
ponents in the posterior region of T. cruzi. In view of previous
reports of acidic vesicles, termed reservosomes, in the poste-
rior region of T. cruzi epimastigotes (9, 12), we analyzed the
relationship between MEST-1 labeling and these vesicles. As a
first step, epimastigotes were incubated with Lysotracker Red,
a specific label of acidic vesicles in eukaryotic cells (Handbook
of Fluorscent Probes and Research Chemicals, Molecular
Probes, Inc., Eugene, Oreg.), fixed with 1% formaldehyde, and
incubated with MEST-1. Colocalization of Lysotracker Red
and MEST-1 was confirmed (Fig. 2).
In contrast to our results, a study by Golgher et al. (3) using
anti-GIPC serum showed a homogeneous label on the epimas-
tigote surface, suggesting the predominant presence of GIPCs.
We therefore characterized the T. cruzi antigen recognized by
MEST-1 and analyzed the glycolipid fractions. Epimastigotes,
culture-derived trypomastigotes, and extracellular amastigotes
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FIG. 1. MEST-1 reactivity with various T. cruzi forms by confocal IFI. (A and B) Epimastigotes; (C and D) metacyclic trypomastigotes; (E and
F) extracellular amastigotes; (G and H) Vero cells infected with trypomastigotes; (I and J) Vero cells infected with amastigotes. (A, C, E, G, and
I) Differential interference contrast (bars show the scale in micrometers); (B, D, F, H, and J) fluorescence. Blue color, MEST-1 reactivity; red color,
nucleus and kinetoplast stained with DAPI.
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FIG. 2. Colocalization of MEST-1 with acidic vesicles. Confocal immunofluorescence microscopy images of T. cruzi epimastigotes labeled with
MEST-1 and Lysotracker Red are shown. (A) Phase contrast (bar, 5 m); (B) Lysotracker Red fluorescence; (C) MEST-1 fluorescence; (D)
overlaid image of DAPI (blue), Lysotracker Red (red), and MEST-1 (green) fluorescence.
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were added to 96-well plates (precoated with 0.1% poly-L-
lysine; 2  106 parasites in the first well), doubly diluted in
subsequent wells, and fixed for 15 min with 0.5% glutaralde-
hyde in cold PBS. MEST-1 reactivity was analyzed by solid-
phase RIA (14). Fixed parasites were delipidated (or not) with
a mixture of isopropanol-hexane-water (IHW) (55:20:25 [vol/
vol/vol], upper phase discarded). Plates were then washed with
PBS and used for solid-phase RIA (13). MEST-1 showed high
reactivity with epimastigotes and extracellular amastigotes and
weak reactivity with cell-derived trypomastigotes (Fig. 3A),
similar to results from IFI. Delipidation of parasites abolished
MEST-1 reactivity, and, as expected, most of the antigenicity
was recovered in the organic extract (Fig. 3B) when the ex-
tracts were adsorbed onto 96-well plates and MEST-1 binding
was detected as described above.
To confirm that MEST-1 recognizes all GIPC molecules and
not only a subpopulation present in acidic vesicles (which
could explain the lack of epimastigote surface labeling with
MEST-1), GIPCs were extracted from epimastigotes, extracel-
lular amastigotes, and cell-derived trypomastigotes by homog-
enizing the parasites (3  108) with 10 ml of isopropanol-
hexane-water. The extracts were evaporated and dialyzed, and
carbohydrate content was determined after densitometry of
HPTLC stained with orcinol-H2SO4 (17). The GIPC fraction
of epimastigotes contained 2 to 3 times more carbohydrate
than that of amastigotes and 7.5 times more than that of
trypomastigotes (data not shown). Aliquots containing about 3
g of carbohydrate of the various GIPC fractions were ana-
lyzed by HPTLC on silica gel 60 plates (Whatman, Inc.,
Clifton, N.J.), using as solvents chloroform-methanol-H2O at
60:40:8 and 25:21:7 (vol/vol/vol). Upon staining with orcinol-
H2SO4 (Fig. 4A), at least five glycolipid components with mi-
gration expected for GIPCs were visualized for epimastigotes,
and six components were visualized for cell-derived trypomas-
tigotes and amastigotes. For HPTLC immunostaining, plates
were soaked in 0.5% polymethacrylate in hexane, dried,
blocked for 2 h with 1% BSA in PBS, incubated overnight with
MAb MEST-1, and incubated with rabbit anti-mouse IgG and
125I-labeled protein A (2  107 cpm per 50 ml of BSA-PBS).
GIPCs were reactive with MEST-1 (Fig. 4B), indicating that
even though GIPC levels vary among different T. cruzi forms
(epimastigotes  amastigotes  trypomastigotes), all GIPCs
express terminal Gal-furanose residues that are recognized by
MEST-1. In order to better understand the role of GIPCs in
the T. cruzi life cycle, we are currently investigating GIPC
metabolic pathways. The relationship between GIPCs and epi-
mastigote reservosomes is still unclear. Soares and DeSouza
(11) showed by cytochemical studies that the main components
of the reservosome matrix are proteins and lipid inclusions.
The data presented here suggest that these inclusions contain
GIPCs, among other lipids.
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FIG. 4. HPTLC of glycolipids from different forms of T. cruzi. (A)
Staining with orcinol-H2SO4; (B) immunostaining with MAb MEST-1.
Lane S, ganglioside standard mixture containing GM3, GM2, GM1,
and GD1; lane 1, glycolipids from epimastigote forms; lane 2, amas-
tigotes; lane 3, cell-derived trypomastigotes.
FIG. 3. Reactivity of MAb MEST-1 with different T. cruzi forms. (A) Parasites (2 106) were serially diluted and adsorbed onto 96-well plates.
Plates were treated with IHW (55:20:25, vol/vol/vol) (,E, and‚) or left untreated (,F, andŒ) and incubated with MEST-1. (B) After treatment
of parasites with IHW, the solvent was transferred to another 96-well plate and evaporated, and adsorbed glycolipid fractions were incubated with
MEST-1.  and , epimastigotes; E and F, cell-derived trypomastigotes; ‚ and Œ, extracellular amastigotes.
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